Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple myeloma accepted for regulatory review in Japan Read more
FDA approves Novartis Kisqali to reduce risk of recurrence in people with HR+/HER2- early breast cancer Read more
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies Read more
Sanofi shipping BEYFORTUS in US to help protect babies against RSV disease; new manufacturing line approved by FDA Read more
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases Read more
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing Read more
Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies Read more
Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies Read more
Global Leaders in Cell Therapy for Autoimmune Diseases Converge at the 2nd Cell Therapy for Autoimmune Disease Summit Read more